OPGN Opgen Inc

OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.

$2.30
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  05/04/2015
Outstanding shares:  38,266,482
Average volume:  1,132,690
Market cap:   $90,308,898
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68373L307
ISIN:        US68373L3078
Sedol:      BHNWR66
Valuation   (See tab for details)
PE ratio:   -2.37
PB ratio:   1.91
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy